Home > News & Opinion > Viewpoint

Viewpoint

  • The urgent need to shorten autism's diagnostic odyssey
    15 July 2014
    Comments ( 8 )

    With the rate of autism now at 1 in 68 people and climbing, the need for solutions that reach the risk population more quickly and effectively has never been more real, say Dennis Wall and Glenn Saxe.

  • How to evaluate new medications for autism
    10 June 2014
    Comments ( 6 )

    There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.

  • Signaling pathways link autism, schizophrenia
    27 May 2014
    Comments ( 3 )

    Autism, schizophrenia and intellectual disability share underlying deficits in pathways that regulate how the brain encodes new experiences, says Jason Shepherd.

  • Misdirected neurons may underlie autism symptoms
    13 May 2014
    Comments ( 2 )

    Proteins that help guide neurons to their correct destination in the brain may be involved in autism, says Christopher Cowan.

  • What the FOX says: Genes that bridge autism, language
    29 April 2014
    Comments ( 4 )

    To understand the role of FOXP2, a gene that links autism and language, researchers should look at its partner genes and at language models such as songbirds, say Genevieve Konopka and Todd Roberts.  

1 2 3 4 15 Next >